Logo image of ALCAR.PA

CARMAT (ALCAR.PA) Stock Fundamental Analysis

EPA:ALCAR - FR0010907956 - Common Stock

0.1288 EUR
+0.01 (+4.21%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALCAR. ALCAR was compared to 57 industry peers in the Health Care Equipment & Supplies industry. ALCAR has a bad profitability rating. Also its financial health evaluation is rather negative. ALCAR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALCAR has reported negative net income.
ALCAR had a negative operating cash flow in the past year.
ALCAR had negative earnings in each of the past 5 years.
ALCAR had a negative operating cash flow in each of the past 5 years.
ALCAR.PA Yearly Net Income VS EBIT VS OCF VS FCFALCAR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

ALCAR's Return On Assets of -121.13% is on the low side compared to the rest of the industry. ALCAR is outperformed by 92.98% of its industry peers.
Industry RankSector Rank
ROA -121.13%
ROE N/A
ROIC N/A
ROA(3y)-95.2%
ROA(5y)-87.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCAR.PA Yearly ROA, ROE, ROICALCAR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALCAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCAR.PA Yearly Profit, Operating, Gross MarginsALCAR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

2

2. Health

2.1 Basic Checks

ALCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCAR has more shares outstanding
The number of shares outstanding for ALCAR has been increased compared to 5 years ago.
The debt/assets ratio for ALCAR is higher compared to a year ago.
ALCAR.PA Yearly Shares OutstandingALCAR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALCAR.PA Yearly Total Debt VS Total AssetsALCAR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALCAR has an Altman-Z score of -6.29. This is a bad value and indicates that ALCAR is not financially healthy and even has some risk of bankruptcy.
ALCAR has a Altman-Z score of -6.29. This is amonst the worse of the industry: ALCAR underperforms 87.72% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.29
ROIC/WACCN/A
WACC5.07%
ALCAR.PA Yearly LT Debt VS Equity VS FCFALCAR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

2.3 Liquidity

ALCAR has a Current Ratio of 2.60. This indicates that ALCAR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.60, ALCAR is in the better half of the industry, outperforming 71.93% of the companies in the same industry.
A Quick Ratio of 1.01 indicates that ALCAR should not have too much problems paying its short term obligations.
ALCAR has a Quick ratio of 1.01. This is comparable to the rest of the industry: ALCAR outperforms 43.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.01
ALCAR.PA Yearly Current Assets VS Current LiabilitesALCAR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

8

3. Growth

3.1 Past

ALCAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.50%, which is quite impressive.
ALCAR shows a strong growth in Revenue. In the last year, the Revenue has grown by 149.16%.
The Revenue has been growing by 46.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.95%
Revenue 1Y (TTM)149.16%
Revenue growth 3Y46.22%
Revenue growth 5YN/A
Sales Q2Q%64.17%

3.2 Future

ALCAR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.65% yearly.
The Revenue is expected to grow by 117.67% on average over the next years. This is a very strong growth
EPS Next Y53.31%
EPS Next 2Y27.7%
EPS Next 3Y24.65%
EPS Next 5YN/A
Revenue Next Year103.62%
Revenue Next 2Y146.09%
Revenue Next 3Y117.67%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALCAR.PA Yearly Revenue VS EstimatesALCAR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALCAR.PA Yearly EPS VS EstimatesALCAR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALCAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCAR.PA Price Earnings VS Forward Price EarningsALCAR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCAR.PA Per share dataALCAR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as ALCAR's earnings are expected to grow with 24.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.7%
EPS Next 3Y24.65%

More info and screens

0

5. Dividend

5.1 Amount

ALCAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARMAT

EPA:ALCAR (9/5/2025, 7:00:00 PM)

0.1288

+0.01 (+4.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)09-10 2025-09-10
Inst Owners0.53%
Inst Owner ChangeN/A
Ins Owners23.06%
Ins Owner ChangeN/A
Market Cap8.26M
Analysts87.27
Price Target4.73 (3572.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)27.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-8.13%
EPS NY rev (3m)-8.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.18
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.21
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS0.11
BVpS-0.54
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -121.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-95.2%
ROA(5y)-87.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.85%
Cap/Sales 21.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.01
Altman-Z -6.29
F-Score3
WACC5.07%
ROIC/WACCN/A
Cap/Depr(3y)22.04%
Cap/Depr(5y)20.77%
Cap/Sales(3y)259.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.95%
EPS Next Y53.31%
EPS Next 2Y27.7%
EPS Next 3Y24.65%
EPS Next 5YN/A
Revenue 1Y (TTM)149.16%
Revenue growth 3Y46.22%
Revenue growth 5YN/A
Sales Q2Q%64.17%
Revenue Next Year103.62%
Revenue Next 2Y146.09%
Revenue Next 3Y117.67%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.27%
EBIT Next 3Y23.36%
EBIT Next 5YN/A
FCF growth 1Y23.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.01%
OCF growth 3YN/A
OCF growth 5YN/A